INCIDENCE OF POLYPHARMACY AND DRUG RELATED PROBLEMS AMONG ELDERLY IN TERTIARY CARE HOSPITAL – A DESCRIPTIVE STUDY
DOI:
https://doi.org/10.22159/ajpcr.2022.v15i9.44618Keywords:
Drug Related Problems, Polypharmacy, Geriatrics, Patient counselling, PrescriptionAbstract
Objective: Drug-related problems are most common in Geriatrics. The increasing number of available drugs and drug users as well as more drug regimens led to many drug related problems which increases the health-care cost, mortality, morbidity, and also decreases the quality of life. The main objective of this study is to assess the incidence of polypharmacy and drug-related problems among elderly admitted in tertiary care hospital.
Methods: The study was conducted in a tertiary care hospital after obtaining ethical clearance from the Institutional Ethical Committee. The medication information along with medical data and patient demographics such as name of the patient, age, sex, chief complaints, laboratory data, diagnosis along with therapeutic data such as name of the prescribed drugs, dose, dosage, frequency, route of administration, duration of treatment, and any new or existing drug-related problems were noted in a case collection form by bed-side counseling, case sheets, laboratory reports and were documented. The drug-related problems (DRPs) were categorized using Pharmaceutical Care Network Europe classification v 9.0 classification. Statistical analysis was done using Chi-square test.
Results: of 151 Participants considered for the study 97 (64.24%) were males and 54 (35.76%) were females. The incidence rate of DRPs was found to be 86.09% and 1.45 DRPs per patient. In a total number of sample population, patients with DRPs were 120 and without DRPs were 21.
Conclusion: DRPs mostly observed in geriatric population as they receive multiple medications for multiple disease conditions and active role of clinical pharmacist is necessary to identify and resolve them. DRPs identified must be accepted by the physicians and cooperation of patients and physician is necessary to resolve DRPs. Further studies are required to prove that the polypharmacy plays a major role in developing DRPs.
Downloads
References
Hsu WT, Shen LJ, Lee CM. Drug related problems vary with medication category and treatment duration in Taiwanese heart failure outpatients receiving case management. J Formos Med Assoc 2016;115:335-42. doi: 10.1016/j.jfma.2015.11.014, PMID 26774679
Movva R, Jampani A, Nathani J, Pinnamaneni SH, Challa SR. A prospective study of incidence of medication related problems in general medicine ward of a tertiary care hospital. J Adv Pharm Technol Res 2015;6:190-4. doi: 10.4103/2231-4040.166502, PMID 26605161
Ahmed B, Nanji K, Mujeeb R, Patel MJ. Effects of polypharmacy on adverse drug reactions among geriatric outpatients at a tertiary care hospital in Karachi: A prospective cohort study. PLoS One 2014;9:e112133. doi: 10.1371/journal.pone.0112133, PMID 25402452
Rieckert A, Trampisch US, Drewelow E, Aneez E, Esmail A, Keller S, et al. Polypharmacy in older patients with chronic diseases: a cross sectional analysis of factors associated with excessive polypharmacy. BMC Fam Pract 2018;19:113.
Dos Santos NS, Marengo LL, Moraes FD, Filho SB. Interventions to reduce the prescription of inappropriate medication in geriatrics. Rev Saúde Publ. 2019;53:1-7.
Patel S, Patel A, Solanki N, Patel V. Study of medication error in hospitalised patients in tertiary care hospital. J Pharm Pract 2018;11:32-6.
Kvarnström K, Airaksinen M, Liira H. Barriers and facilitators to medication adherence: A qualitative study with general practitioners. BMJ Open 2018;8:e015332. doi: 10.1136/bmjopen-2016-015332, PMID 29362241
Jin H, Kim Y, Rhie SJ. Factors affecting medication adherence in elderly people. Patient Prefer Adherence 2016;10:2117-25. doi: 10.2147/PPA. S118121, PMID 27799748
Edwards IR, Aronson JK. Adverse drug reactions: Definitions, diagnosis and management. Lancet 2000;356:1255-9. doi: 10.1016/ S0140-6736(00)02799-9, PMID 11072960
Adhikari A, Bhattacharya N, Indu R, Ray M, Bhattacharya S. Evaluation of adverse drug reactions (ADRs) in tertiary care hospital of Kolkata, West Bengal, India. J Young Pharm 2017;9:311-4.
Greco WR, Bravo G, Parsons JC. The search for synergy: A critical review from a response surface perspective. Pharmacol Rev 1995;47:331-85. PMID 7568331
Kukarni V, Bora SS, Saji M, Sundaran S, Sirisha S. A study on drug-drug interactions through prescription analysis in a south Indian teaching hospital. Ther Adv Drug Saf 2013;4:141-6.
Lim XY, Yea QQ, Kng GL, Chung WL, Yap KZ. Validation of a drug related problem classification system for the intermediate and long term care setting in Singapore. Pharmacol (Basel) 2018;6:109.
Van Mil F. Drug related problems: A cornerstone for pharmaceutical care. J Malta Coll Pharm Pract 2005;5:5-8.
Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf 2014;13:57-65. doi: 10.1517/14740338.2013.827660, PMID 24073682
Oliveira MV, Buarquea DC. Polypharmacy and the use of potentially inappropriate medications among aged inpatients. Geriatrgerontol Aging 2018;12:38-44.
Willeboordse F, Grundeken LH, van den Eijkel LP, Schellevis FG, Elders PJ, Hugtenburg JG. Information on actual medication use and drug related problems in older patients: Questionnaire or interview. Int J Clin Pharm 2016;38:380-7. doi: 10.1007/s11096-016-0258-9, PMID 26830412
Harish CV, Belavigi D, Patil AN, Pattanaik S, Kakkar A, Kasudhan KS. Assessment of the impact of clinical pharmacology consultations provided to hospital clinicians from the drug information center an outcome research in a developing country. J Pharm Pract 2019;34:581-6.
Zhu Y, Liu C, Zhang Y, Shi Q, Kong Y, Wang M, et al. Identification and reolution of drug related problems in a tertiary hospital respiratory unit in China. Int J Clin Pharm 2019;41:1570-7. doi: 10.1007/ s11096-019-00922-3, PMID 31654364
Published
How to Cite
Issue
Section
Copyright (c) 2022 M. Tabitha Sharon, Chaithra, Vasavi, Madhuri, Bhargavi
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.